Background: HIV-infected patients (HIP) who ignore their HIV status or those without viral suppression, may develop Pneumocystis jirovecci pneumonia (PJP) and require admission to an intensive care unit (ICU), with a mortality rate of ICU HIV patients with PJP can still be up to 60%. Our aims are to describe clinical characteristics of patients with proven Aids-related PJP and determine factors related with mortality.
Methods & Materials: Among 1122 HIP admitted to ICU of an Infectious Diseases Hospital between 2006 and 2016, 63 had PJP. Clinical features, radiological and laboratory investigations and outcomes were reviewed. Univariate analysis was performed to identify factors related to death. We performed descriptive statistics on percentage (%), median (Me), mean (M) and range. A p value of < 0.05 was considered significant Results: Incidence was 0,056. The M age was 37 (14-76) years. 65% were male. 92% cases occurred with cell count CD4 + less than 100 cells/L with a Me of 52. 90% did not receive highly active antiretroviral therapy. 75% presented weight loss > 10% during the last 6 months, Karnofsky scale > 50 or hypoalbuminemia < 2,6 g/L. 70% presented diffuse bilateral interstitial infiltrates on chest X ray and 10% pneumothorax. 87% presented severe acute hypoxemic respiratory failure on admission, 40% required mechanical ventilation (MV). APACHE II (Acute Physiology and Chronic Health Evaluation II) score ≥13 points in 76% of the patients. Initial treatment was trimethoprim-sulfamethoxazole (and corticosteroids) which should be suspended due to adverse events in 25% (15% granulocytopenia, 5% exanthema and 5% hyperkalemia), it was replaced by intravenous pentamidine. Overall mortality was 43%. CD4 + < 100 cells/L, respiratory failure, MV and APACHE II ≥13 points was related to mortality (p<0,05)
Conclusion: In our serie MV, severity scores and severe immunosuppression were associated with mortality. Patients with CD4 > 100 cells survived. Malnutrition was related with mortality but p was not statistically significant. Consider initiate empirical PJP treatment in severe pneumonia in HIP. Background: Cryptococcus neoformans is neurotropic and provokes onset of cryptococcal meningitis. In HIV/AIDS patients it is a dangerous opportunistic infection. In Europe and the United States, about 80% of the cryptococcosis cases were associated with HIV/AIDS. But in China, most of patients with cryptococcal meningitis were not HIV victims. It is unclear whether these patients have other underlying diseases except HIV/AIDS and they are mostly in immunodeficient or immunocompetent state.
Methods & Materials: A comprehensive analysis of the reported cases of cryptococcal meningitis in China was conducted, covering publications from 1981 to 2013 from CNKI (China National Knowledge Infrastructure) database with key words of cryptococcus and meningitis and case.
Results: Among the 306 reports and 6514 cases about cryptococcal meningitis, there were 21% patients with HIV infection, 39% with other underlying diseases and 40% without identifiable underlying diseases. Main underlying diseases in non-HIV/AIDS patients were tuberculosis (10.46%), liver disease (9.83%), systemic lupus erythematosus (7.00%), diabetes (5.26%), kidney disease (3.16%), lung disease (2.97%), and cancer (2.01%). From 1981 From -2013 year, total patients of cryptococcal meningitis were increased, the patients without underlying diseases were increased more than those with other underlying diseases, but the patients with HIV/AIDS were decreased after 2005. Patients who received treatment of amphotericin B (AmB) with 5-flucytosine, AmB with Fluconazole, and the combination of AmB + 5-FU + FCZ were 495, 411, 266 persons (total 1501 cases) and got a total efficiency of 70.1%, 70.8%, and 74.8% respectively. The survival rate of cryptococcal meningitis patients without HIV/AIDS is higher than those with HIV/AIDS (p < 0.05).
Conclusion:
The result shows that most patients of cryptococ-Background: The type I fungal iterative Polyketide synthase (PKS) is found in many toxigenic Aspergillus species. PKS is an important biological non-reducing (NR) type enzymes. It possesses highly active Acyl Carrier Protein (ACP) domain that is implicated in thiol ester-bound intermediates in involved in fungal polyketides, fatty acids and other non-ribosomal peptides formation. These natural polyketide and fatty acids are participated in formation of aflatoxin biosynthesis. These aflatoxins are highly responsible for hepatocarcinhgenesis (HCC), one of commonest cancer among humans living in tropical regions. The HCC has also been shown the synergetic effect with viral infections especially hepatitis B. The risk of HCC is drastically increased under episodic exposure of aflatoxin contaminated feed and hepatitis B that can be fatal if delay in diagnosis and proper treatment.
Methods & Materials: The ACP domain as 3D coordinates 2KR5.pdb of polyketide synthase of Aspergillus parasiticus is taken from RCSB. The requisite antifungal ligand files for docking purpose i.e. neoeriocitrin (CID: 114627), blasticidin-S (CID: 16380), blasticidin-S hydrochloride (CID: 258) and pipernomaline (CID: 9974595) protein were retrieved from PubChem Database. The protein preparation, ligand library preparation, sites identification and docking (LibDock Score) were performed by using dynamic software Discovery Studio version 3.5.
Results: In the three different sites, site 1 (x: -7.589; y: -2.949; z: 4.007) shown the most effective docking results. At this site 1, the highest LibDock score of 160.282 for 2KR5-neoeriocitrin had shown the successful inhibition of polyketide synthase. Lys4, Asp80, Gly84, Gly86, Asp87 and Gly89 are the amino acides of the protein that are interacted with neoeriocitrin.
Conclusion: The Computational study and prediction of three different active sites in ACP domain of PKS of Aspergillus parasiticus had shown the successful interaction with proper ligands. The neoeriocitrin and similar other organic compounds are the very effective flavonoid found in grape fruits that can essentially use in treating HCC and Hepatitis patients. Methods & Materials: A cross-sectional study was conducted on 26 dairy farms drawn from 4 local government areas in the state. A total of 300 composite milk samples were collected from 300 cows-in-milking and examined using molecular techniques.
Results: 37 (12.3%) fungal isolates were identified using the API 20C AUX as; (9) Candida albicans, (4) Candida famata, (4) Candida krusei, (1) Candida boidinii, (1) Candida pelliculosa, (1) Candida lusitaniae, (5) Trichosporon mucoides, (1) Cryptococcus humicola, (1) Cryptococcus laurentii, (1) Cryptococcus albidus, (2) Saccharomyces cerevisiae, (2) Stephanoascus ciferrii, (2) Rhodotorula mucilaginosa, (1) Kloeckera spp., (1) Kodamaea ohmeri and (1) Geotrichum capitatum. All C. albicans had the ability to survive high temperature, produced germ tubes in human serum and formed chlamydospores in corn meal-tween 80 Agar. In-vitro sensitivity test using five antimycotic agents showed that 85% of the isolates were sensitive to amphotericin B, followed by griseofulvin, nystatin, variconazole and fluconazole in decreasing order. Nested PCR of the D1/D2 domains of the 26S rRNA gene of 11 yeast isolates showed they all had a distinct band-600 bp. DNA sequencing and GenBank BLASTN of the eleven genes identified them as:
(3) Candida albicans, (1) Saccharomyces cerevisiae and (7) Pichia Kudriavzevii. The D1/D2 26S rRNA gene sequences were 93-100% identical for yeast isolates within the same species. Phylogenetic reconstruction based on the D1/D2 26S rRNA gene sequences grouped them into 3 clusters and showed heterogeneity in C. albicans.
Conclusion: The relatively high prevalence of yeasts in bovine subclinical mastitis in dairy herds could significantly reduce milk production and cause economic losses. The milk samples contained diverse yeast species including isolates of the pathogenic yeast C. albicans and this raises the possibility of milk and dairy products being vehicles for transmission of pathogenic yeasts. It is therefore recommended that the farmers practice good milking hygiene, milk clinically infected cows last, cull chronic mastitis cases, treat clinically infected cows and administer dry period therapy to their cows.
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